financetom
Business
financetom
/
Business
/
General Motors Provided 'Very Strong' 2025 Guidance Despite 'Choppy Waters' in EV Macro, Wedbush Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
General Motors Provided 'Very Strong' 2025 Guidance Despite 'Choppy Waters' in EV Macro, Wedbush Says
Jan 28, 2025 8:49 AM

11:25 AM EST, 01/28/2025 (MT Newswires) -- General Motors ( GM ) provided "very strong" guidance for 2025 despite "choppy waters" in the electric vehicle macro, Wedbush said in a note Tuesday.

Wedbush analysts, including Daniel Ives, said the company's above-consensus 2025 adjusted earnings per share guidance of $11 to $12 reflects GM's prudence on cost management, "with continued emphasis on fixed cost discipline and efficiency."

The analysts said the company has "strong tailwinds into 2025 despite EV tax credit uncertainty."

In the EV space, the automaker "was double its EV market share" throughout fiscal 2024 and is planning to debut additional EV models in 2025, which point to "growing EV profitability moving forward."

Wedbush maintained an outperform rating and $60 price target.

GM shares were down nearly 10% in recent Tuesday trading.

Price: 49.83, Change: -5.09, Percent Change: -9.27

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Oxford Lane Capital Adopts Share Repurchase Plan
Oxford Lane Capital Adopts Share Repurchase Plan
Mar 20, 2025
05:19 PM EDT, 03/20/2025 (MT Newswires) -- Oxford Lane Capital ( OXLC ) said Thursday its board approved a share repurchase program of up to $150 million. The share repurchase program is valid through March 20, 2026, according to the company. ...
Allurion Technologies Reports Positive Ballon Combination Study Results; Shares Jump
Allurion Technologies Reports Positive Ballon Combination Study Results; Shares Jump
Mar 20, 2025
05:16 PM EDT, 03/20/2025 (MT Newswires) -- Allurion Technologies ( ALUR/WS ) said Thursday that initial trial results from the Allurion ( ALUR/WS ) balloon in combination with semaglutide showed total body weight loss and lean body mass gains. The company treated 52 patients in the study and the average total body weight loss was 20.3% after eight months while...
Rhythm Pharmaceuticals Regains Licensing Rights to Imcivree Obesity Drug
Rhythm Pharmaceuticals Regains Licensing Rights to Imcivree Obesity Drug
Mar 20, 2025
05:29 PM EDT, 03/20/2025 (MT Newswires) -- Rhythm Pharmaceuticals ( RYTM ) said late Thursday it has reacquired rights to its Imcivree obesity medication throughout mainland China, Hong Kong and Macau after terminating its 2021 licensing deal with RareStone Group. As part of the agreement to regain the global franchise for Imcivree, Rhythm said it will repay $6.3 million in...
Lennar Shares Slide After 'Weakness In The Market' Leads To Lower Sales Prices And Gross Margin
Lennar Shares Slide After 'Weakness In The Market' Leads To Lower Sales Prices And Gross Margin
Mar 20, 2025
Lennar Corp. ( LEN ) released its first-quarter results after Thursday's closing bell. Here's a look at the details from the report.  The Details: Lennar ( LEN ) reported quarterly earnings of $2.14 per share. which beat the analyst consensus estimate of $1.73. Quarterly GAAP revenue came in at $7.63 billion, beating the consensus estimate of $7.43 billion. Read Next: Darden...
Copyright 2023-2026 - www.financetom.com All Rights Reserved